VBI Vaccines Secures $50M Debt Financing from K2 HealthVentures

Ontario Industry Updates
Written By Guest User
VBI_Logo_New-Blue-72.jpg

VBI Vaccines Inc. has announced that it has entered into a debt financing facility for up to $50 million with K2 HealthVentures. As VBI advances its pipeline candidates through the next clinical and regulatory milestones, the partnership will strengthen the company’s financial position and flexibility.

VBI Vaccines is a commercial-stage biopharmaceutical company developing next-generation infection disease and immuno-oncology vaccines.

Guest User
Previous

Spiderwort closes $2.5M USD Series Seed Financing
Next

Flosonics Medical Among Winners of the Vale COVID-19 Challenge